Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Syndax Pharmaceuticals Inc has a consensus price target of $34.31 based on the ratings of 16 analysts. The high is $45 issued by HC Wainwright & Co. on August 15, 2024. The low is $21 issued by Morgan Stanley on October 12, 2021. The 3 most-recent analyst ratings were released by Citigroup, HC Wainwright & Co., and B of A Securities on August 16, 2024, August 15, 2024, and August 15, 2024, respectively. With an average price target of $36.67 between Citigroup, HC Wainwright & Co., and B of A Securities, there's an implied 101.68% upside for Syndax Pharmaceuticals Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Syndax Pharmaceuticals (NASDAQ:SNDX) was reported by Citigroup on August 16, 2024. The analyst firm set a price target for $34.00 expecting SNDX to rise to within 12 months (a possible 87.02% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Syndax Pharmaceuticals (NASDAQ:SNDX) was provided by Citigroup, and Syndax Pharmaceuticals maintained their buy rating.
There is no last upgrade for Syndax Pharmaceuticals
The last downgrade for Syndax Pharmaceuticals Inc happened on January 31, 2024 when Scotiabank changed their price target from $36 to $23 for Syndax Pharmaceuticals Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Syndax Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Syndax Pharmaceuticals was filed on August 16, 2024 so you should expect the next rating to be made available sometime around August 16, 2025.
While ratings are subjective and will change, the latest Syndax Pharmaceuticals (SNDX) rating was a maintained with a price target of $30.00 to $34.00. The current price Syndax Pharmaceuticals (SNDX) is trading at is $18.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.